Imaging and quantification of placental terminal villi microvasculature and nuclear characteristics in preeclampsia.

Eur J Obstet Gynecol Reprod Biol

Department of Genetics and Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; Interdisciplinary Centre for Clinical Research IZKF, University Hospital RWTH Aachen 52074 Aachen, Germany. Electronic address:

Published: March 2025

Globally, at least 10 % of maternal deaths, caused by obstetric complications during pregnancy, are linked to preeclampsia or eclampsia. Preeclampsia-induced placental hypoxia leads to vascular injury and syncytial knot formation in terminal villi. Early delivery of preeclampsia placentas complicates comparisons with normotensive term placentas, while the placenta's non-planar structure limits the effectiveness of 2D histology for vascular analysis. This study used multiphoton microscopy to quantify 3D morphological differences in terminal villi between late-onset preeclampsia and control pregnancies. 7 late-onset preeclampsia (Gestational age: 37.3 weeks) and 10 control (Gestational age: 38.3 weeks) placentas were stained for nuclei and vasculature, optically cleared using ethyl-cinnamate, imaged with multiphoton microscopy, and analysed semi-automatically. Image quantification revealed a 42 % decrease in vascular fraction and a 97 % increase in syncytial knot density in late-onset preeclampsia samples, both statistically significant. No differences were observed in surface area-to-volume ratios, individual syncytial knot volume, or microvascular characteristics, including branchpoint density, vessel length, branching angle, straightness, and diameter. By analysing placentas at comparable gestational ages, we demonstrated that late-onset preeclampsia is characterized by decreased vascular content and increased syncytial knot density, while individual syncytial knot size and microvascular architecture remain unchanged. These findings enhance our understanding of late-onset preeclampsia pathophysiology and could provide a basis to distinguish late-onset preeclampsia from other phenotypes, such as early-onset preeclampsia, highlighting potential differences in disease mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2025.03.015DOI Listing

Publication Analysis

Top Keywords

late-onset preeclampsia
24
syncytial knot
20
terminal villi
12
preeclampsia
10
multiphoton microscopy
8
gestational age
8
knot density
8
individual syncytial
8
late-onset
6
syncytial
5

Similar Publications

Imaging and quantification of placental terminal villi microvasculature and nuclear characteristics in preeclampsia.

Eur J Obstet Gynecol Reprod Biol

March 2025

Department of Genetics and Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; Interdisciplinary Centre for Clinical Research IZKF, University Hospital RWTH Aachen 52074 Aachen, Germany. Electronic address:

Globally, at least 10 % of maternal deaths, caused by obstetric complications during pregnancy, are linked to preeclampsia or eclampsia. Preeclampsia-induced placental hypoxia leads to vascular injury and syncytial knot formation in terminal villi. Early delivery of preeclampsia placentas complicates comparisons with normotensive term placentas, while the placenta's non-planar structure limits the effectiveness of 2D histology for vascular analysis.

View Article and Find Full Text PDF

Preeclampsia is a complex, progressive multisystem hypertensive disorder during pregnancy that significantly contributes to increased maternal and perinatal morbidity and mortality. Two screening algorithms are in clinical use for detecting preeclampsia: first-trimester screening, which has been developed and validated for predicting early-onset preeclampsia but is less effective for late-onset disease; and the sFlt-1:PlGF biomarker ratio (soluble tyrosine kinase and placental growth factor) used in suspected cases of preeclampsia. This ratio has a high negative predictive value, allowing for the reliable exclusion of the disease.

View Article and Find Full Text PDF

Preeclampsia, affecting 2-4% of pregnancies worldwide, poses a substantial risk to maternal health. Late-onset preeclampsia, in particular, has a high incidence among preeclampsia cases. However, existing prediction models are limited in terms of the early detection capabilities and often rely on costly and less accessible indicators, making them less applicable in resource-limited settings.

View Article and Find Full Text PDF

Secondary prevention of preeclampsia.

Front Cell Dev Biol

February 2025

Department Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Preventing preeclampsia (PE) is crucial for the wellbeing of the mother, fetus, and the neonate with three levels: primary, secondary, and tertiary. Secondary prevention involves pharmacological therapies aimed at stopping the disease's progression before clinical signs. The predominant approach currently employed is the daily administration of low dose Aspirin and calcium.

View Article and Find Full Text PDF

Introduction: Sphingolipids, essential to trophoblast and endothelial function, may impact inflammation in preeclampsia. However, their specific role in late-onset preeclampsia remains unclear. To address this research gap, we analyzed sphingolipid profiles in pregnancies at high risk for preeclampsia development to identify potential biomarkers and clarify their role in disease pathogenesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!